Cargando…
Financing equitable access to antiretroviral treatment in South Africa
BACKGROUND: While South Africa spends approximately 7.4% of GDP on healthcare, only 43% of these funds are spent in the public system, which is tasked with the provision of care to the majority of the population including a large proportion of those in need of antiretroviral treatment (ART). South A...
Autores principales: | Cleary, Susan, McIntyre, Di |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895746/ https://www.ncbi.nlm.nih.gov/pubmed/20594368 http://dx.doi.org/10.1186/1472-6963-10-S1-S2 |
Ejemplares similares
-
The cost-effectiveness of Antiretroviral Treatment in Khayelitsha, South Africa – a primary data analysis
por: Cleary, Susan M, et al.
Publicado: (2006) -
Claims on health care: a decision-making framework for equity, with application to treatment for HIV/AIDS in South Africa
por: Cleary, Susan M, et al.
Publicado: (2011) -
South Africa’s protracted struggle for equal distribution and equitable access – still not there
por: van Rensburg, Hendrik CJ
Publicado: (2014) -
Setting the research and implementation agenda for equitable access to surgical care in South Africa
por: Rayne, Sarah, et al.
Publicado: (2017) -
Exploring inequalities in access to and use of maternal health services in South Africa
por: Silal, Sheetal P, et al.
Publicado: (2012)